Home | Introduction | Site Map | Success Stories | Research | Products | FAQ | Contact Us | WWC Audio |

 

 • Introduction
 •
Important Warning  
 •
About Vitamin B17
 •
Vitamin B17 as Preventative
 •
Metabolic Therapy in Cancer
 • B17 In Metabolic Therapy
 •
Laetrile and Cyanide
 •
Graphic on Action of B17
 •
Frequently Asked Questions
 •
B17 Therapy Components
 •
Accessory Supplements
 •
B17 Therapy Overview
 •
Therapies and Protocols
 •
What is in B17 Therapy?
 •
Maintenance Dosages
 •
Accessory Therapies
 •
Positive Thinking
 •
Implementing Changes
 •
Behaviour of Tumours
 •
Criteria For Evaluation
 •
B17 - Sickle Cell Anaemia
 •
Fluoridation-linked cancer
 •
Contacts 
 •
In God We Trust
 •
References

•  More Studies, Research









 

 

CHAPTER VI

AMYGDALIN STABILITY TEST
Q. F. B. Petra Beltran Corona

Chief of the Production Dept. of KEMSA LABS.

Stability Experiments of Amygdalin in an Aqueous Solution
of 300 Mg/MI of Distilled Water.
(Kemdalin-S 3G/10 MI)


 

LOT DATE OF MANUFACTURE DATE OF ANALYSIS VARIATION IN CONCENTRATION %
No. 7

No. 8

No. 9

No. 10

No. 11

No. 12

4-VI-75

9-VI-75

12-VI-75

14-VI-75

16-VI-75

18-VI-75

22-VII-80

22-VII-80

22-VII-80

22-VII-80

22-VII-80

22-VII-80

36 mg.

81 mg.

57 mg.

90 mg.

105 mg.

66 mg

1.2

2.7

1.9

3.0

3.5

2.2

 
 

 

Comment
    The average variation of loss was 2.42% in five years, which is under the 10% in three years authorized by the Secretary of Health and Welfare of Mexico.

 

 

2001 Worldwithoutcancer.org.uk
By Accessing this web site you accept  all its terms and conditions.

©Copyright 2000 - Worldwithoutcancer.org.uk - PO Box 2038 - Leigh-on-Sea - SS9 2ZB - UK
Home | Introduction | Site Map | Success Stories | Research | Products | FAQ | Contact Us | WWC Audio |